Effectiveness of Nurse Lead Telehealth Consultations in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Brief Summary

Detailed Description

COPD is among the most common reasons for illness and fatality in adults worldwide, and it is expected that this trend will escalate radically by 2020 (1). Approximately 29% of patients admitted to Hospital with exacerbation will be readmitted within the first month (2), and after one year 46% of patients will have been readmitted on one or more occasions due to exacerbation (3). Therefore, trials have been carried out using different forms of digitally supported distance health interventions (telehealth nurse consultations) (4) of patients with COPD with a view to reducing the number of readmissions in a reliable way, measured in relation to mortality. Thus in these trials there are a certain indication that use of telehealth nurse consultations of patients with COPD is a treatment initiative that reliably can reduce the number of COPD patients readmitted with exacerbation. The number of randomized telehealth studies are however few (4;5), and there is a lack of documentation of the effect of telehealth monitoring. Therefore, a large randomized telehealth study with a clear set up was necessary. This study is a randomized multicenter trial that will take place at the acute admissions department and lung department at Odense University Hospital,Denmark We hypothesized that in a period of 26 weeks: 1. The total number of readmissions can be reduced with 14% 2. The time to the first readmission will be prolonged 3. The number of readmissions with exacerbation can be reduced after telehealth consultations as a supplement to the conventional treatment compared with conventional treatment 4. The total number of readmission days can be reduced after telehealth consultations as a supplement to the conventional treatment compared with conventional treatment 5. The total number of readmission days with exacerbation can be reduced after telehealth consultations as a supplement to the conventional treatment compared with conventional treatment 6. The mortality rate will remain unchanged after the telehealth consultations as a supplement to the conventional treatment compared with conventional treatment

Primary Outcomes

Secondary Outcomes

• The mortality rate(at 26 weeks weeks after discharge)
• The number of hospital readmissions with exacerbation(at 26 weeks after discharge)
• The duration to the first readmission(at 26 weeks after discharge)
• The number of days readmitted(days 26 weeks after discharge)
• The number of days readmitted with exacerbation(days 26 weeks after discharge)